...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

KK2, Buckeyes & 10BagR - A number of years ago at an AGM McCaffrey went into this long blurb about not announcing the results of any FDA meetings until they had received a conformation letter about what they had agreed upon at the said meeting. He went no further to say the FDA's goal was to have those letters out about a month after the said meeting. If the meeting was to occur in the first half of Aug and it's expected that a letter would be received about a month after that then for my purposes I'm not expecting to hear anything about this meeting until mid September.

This news release was about NFLD, why are people expecting it to say something about COVID and a meeting with the FDA?

tada 

Share
New Message
Please login to post a reply